69214-22-8 Usage
Uses
Used in Pharmaceutical Industry:
Imidazo[1,2-a]pyridin-8-ol (9CI) serves as a building block for the synthesis of other compounds, contributing to the development of novel pharmaceutical agents. Its unique structure allows for the creation of diverse molecules with potential therapeutic properties.
Used in Research Applications:
In the realm of research, Imidazo[1,2-a]pyridin-8-ol (9CI) is utilized as a ligand in coordination chemistry. Its ability to form stable complexes with metal ions makes it a valuable tool for studying the properties and reactivity of metal complexes.
Used as a Potential Drug Candidate:
Imidazo[1,2-a]pyridin-8-ol (9CI) is also considered a potential drug candidate for the treatment of various diseases. Its precise properties and therapeutic potential are currently under investigation by researchers, who are exploring its efficacy and safety in treating specific medical conditions.
While the specific applications and industries for Imidazo[1,2-a]pyridin-8-ol (9CI) are still being explored, its unique structure and properties make it a promising compound for future advancements in pharmaceuticals, coordination chemistry, and drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 69214-22-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,9,2,1 and 4 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 69214-22:
(7*6)+(6*9)+(5*2)+(4*1)+(3*4)+(2*2)+(1*2)=128
128 % 10 = 8
So 69214-22-8 is a valid CAS Registry Number.
69214-22-8Relevant academic research and scientific papers
COMPOUNDS, COMPOSITIONS AND METHODS FOR STABILIZING TRANSTHYRETIN AND INHIBITING TRANSTHYRETIN MISFOLDING
-
, (2021/08/06)
Provided herein are compounds having activity against TTR related conditions, and pharmaceutically accepted salts and solvates thereof. Also provided are methods of using the compounds for inhibiting and preventing TTR aggregation and/or amyloid formation in the peripheral nerves, kidney, cardiac tissue, eye and CNS, and of treating a subject with peripheral TTR amyloidosis.
BICYCLIC ETHER O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLUCOPYRANOSIDASE INHIBITORS
-
Paragraph 00308, (2020/08/22)
Described herein are compounds represented by formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising the same and methods of preparing and using the same. The variables Ar, X, R1, R3, R 4, Y1, Y2, n and p are as defined herein.
SYNTHESIS OF NEW HETEROCYCLIC PHENOLS: 8-HYDROXY-IMIDAZOPYRIDINE
Rydzkowski, R.,Blondeau, D.,Sliwa, H.
, p. 2571 - 2574 (2007/10/02)
Preparation of the unknown title compound has been achieved by condensation of 2-amino-3-hydroxy-pyridine with chloroacetaldehyde.Activation by the free phenolic hydroxyl allows preferential nitration of the pyridine ring, in marked contrast to the behavior of the related ethers which suffer electrophilic substitution on the imidazole moiety, as usual in the series.
